NCT06451692 Prioritising Patient Medication Review: Hospitals Reaching Out
| NCT ID | NCT06451692 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern Denmark |
| Condition | Medication Review |
| Study Type | INTERVENTIONAL |
| Enrollment | 800 participants |
| Start Date | 2024-06-17 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 800 participants in total. It began in 2024-06-17 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To examine the effect of a cross-sectoral medication review intervention to admitted multi-morbid, polypharmacy patients aged 65+ at SHS in two settings; an acute admission unit (typical admission time \< 48 hours) and a medical outpatient setting (patients routinely visits for follow-up, diagnosis or treatment, but do require a bed or overnight care).
Eligibility Criteria
Inclusion Criteria: * all hospitalized patients who are prescribed at least seven medications specified in the Electronic Patient Journal (EPJ) at admission Exclusion Criteria: * terminal patients or patients with a short life expectancy, patients residing in another region, patients who are discharged on the day of inclusion, and finally patients who do not speak Danish.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06451692 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Medication Review. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06451692 currently recruiting?
Yes, NCT06451692 is actively recruiting participants. Contact the research team at Joo.Hanne.Poulsen.Revell@rsyd.dk for enrollment information.
Where is the NCT06451692 trial being conducted?
This trial is being conducted at Aabenraa, Denmark.
Who is sponsoring the NCT06451692 clinical trial?
NCT06451692 is sponsored by University of Southern Denmark. The trial plans to enroll 800 participants.